Connor, Clark & Lunn Investment Management (CC&L)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
|
|||||
|
2025
Q1 | $1.66M | Sell |
|
|||||
|
2024
Q4 | $4.94M | Sell |
|
|||||
|
2024
Q3 | $7.61M | Sell |
|
|||||
|
2024
Q2 | $22.2M | Sell |
|
|||||
|
2024
Q1 | $23.8M | Sell |
|
|||||
|
2023
Q4 | $36.6M | Buy |
|
|||||
|
2023
Q3 | $6.59M | Sell |
|
|||||
|
2023
Q2 | $19.4M | Buy |
|
|||||
|
2023
Q1 | $2.04M | Sell |
|
|||||
|
2022
Q4 | $26.7M | Buy |
|
|||||
|
2022
Q3 | $19.4M | Buy |
|
|||||
|
2022
Q2 | $15.1M | Buy |
|
|||||
|
2022
Q1 | $11.2M | Buy |
|
|||||
|
2021
Q4 | $10.2M | Buy |
|
|||||
|
2021
Q3 | $8.52M | Buy |
|
|||||
|
2021
Q2 | $2.94M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $7.8M | Sell |
|
|||||
|
2020
Q1 | $27.6M | Sell |
|
|||||
|
2019
Q4 | $34.4M | Buy |
|
|||||
|
2019
Q3 | $13.5M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Sell |
|
|||||
|
2019
Q1 | $17.7M | Buy |
|
|||||
|
2018
Q4 | $6.32M | Sell |
|
|||||
|
2018
Q3 | $16.2M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.59M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $5.9M | Buy |
|